Literature DB >> 7123042

Tissue eosinophilia in human coccidioidomycosis.

R M Echols, D L Palmer, G W Long.   

Abstract

Eosinophilia in peripheral blood and tissue of patients with coccidioidomyocsis was reviewed in an examination of the importance of this cellular response to Coccidioides immitis. Peripheral blood eosinophilia (greater than 5%) was found in each of two patients with primary infection but was markedly more pronounced (27%-53%) in three of five patients with disseminated coccidioidomycosis. Unusually large numbers of tissue eosinophils and organized microabscesses containing eosinophils were found in six patients with progressive or disseminated disease. These six patients all demonstrated cutaneous anergy to coccidioidin. Eosinophilic microabscesses were found surrounding rupturing spherules and free endospores. Phagocytosis of free endospores was not demonstrated by the technique used. The bone marrow of two patients with disseminated disease showed a marked increase in eosinophilic myeloid precursors; this result suggested the presence of an eosinophilopoietin. Although peripheral blood eosinophilia has been explained as a hypersensitivity response to C. immitis that represents a favorable prognosis, the data reported herein suggest that peripheral blood eosinophilia of greater than 20% and the presence of eosinophilic microabscesses correlate with progressive or disseminated infection and thus are indicative of a poor prognosis.

Entities:  

Mesh:

Year:  1982        PMID: 7123042     DOI: 10.1093/clinids/4.3.656

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

1.  Cutaneous manifestations of endemic mycoses.

Authors:  Jeannina A Smith; James Riddell; Carol A Kauffman
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 2.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  High eosinophils after HALO training: an active-duty soldier with recent travel, nonproductive cough, and eosinophilia.

Authors:  Chad B McBride; Paige Waterman; Richard F Trotta
Journal:  Medscape J Med       Date:  2008-02-26

4.  Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).

Authors:  Chiung-Yu Hung; Angel Gonzalez; Marcel Wüthrich; Bruce S Klein; Garry T Cole
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

Review 5.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 6.  Eosinophilia in Infectious Diseases.

Authors:  Elise M O'Connell; Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

Review 7.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

Review 9.  Coccidioidomycosis.

Authors:  J N Galgiani
Journal:  West J Med       Date:  1993-08

Review 10.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.